http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113588945-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9c50e58cc31fe1558714adcfdd249697 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-54326 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-56983 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N21-82 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-543 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-569 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N21-82 |
filingDate | 2021-07-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_58161d0b6a3ac641f62abef2e53a01f9 |
publicationDate | 2021-11-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-113588945-A |
titleOfInvention | Novel coronavirus neutralizing antibody detection reagent and kit based on chemiluminescence |
abstract | The invention belongs to the technical field of biology, and particularly relates to a novel coronavirus neutralizing antibody detection reagent and a kit based on chemiluminescence. A novel coronavirus neutralizing antibody detection reagent is a novel coronavirus spike protein pseudovirus with a magnetic bead marker. The invention discloses a kit, which comprises novel coronavirus spike protein pseudovirus marked by magnetic beads, recombinant human ACE2 protein marked by acridinium ester, superparamagnetic beads, chemiluminescence starting liquid and other related materials. The invention quantitatively analyzes whether the neutralizing antibody for resisting the S protein of the novel coronavirus is generated in vivo after the novel coronavirus is infected or inoculated by a magnetic particle chemiluminescence method, and calculates the inhibition rate of the neutralizing antibody, thereby quantitatively analyzing whether the protective antibody is generated in vivo after the novel coronavirus is infected or inoculated, and providing first-hand data for later-stage serological epidemic disease general survey and vaccination guidance of the novel coronavirus. |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-114371286-A |
priorityDate | 2021-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 580.